Literature DB >> 16725317

The minipig in toxicology.

Ove Svendsen1.   

Abstract

The use of pigs (Sus scrofa) in biomedical research is well established in particular in surgical and physiological research. For years both pigs and minipigs have been used in pharmacology and toxicology to answer specific questions when the more conventional species have been found unsuitable. The development of minipigs has resulted in strains of more manageable size than the domestic pig. Because of their well-accepted physiological and other similarities to humans, minipigs are becoming increasingly attractive toxicological and pharmacological models. There are several strains of minipigs (Göttingen, Yucatan, Sinclair, Hanford and other). This presentation is based on experience primarily with the Göttingen minipigs. In toxicology in Europe minipigs have become very popular for pharmaceutical studies in place of dogs and primates. Minipigs have been shown to be sensitive to a wide variety of drugs and chemicals. It has become obvious that minipigs can be used for all routes of administration, and in many cases are preferable to dogs or primates for metabolic or pharmacological reasons. There are advantages over the traditional non-rodent species in relation to specific responses to particular drug classes. Their use in general toxicology testing employing the continuous intravenous infusion, dermal or inhalation route has been described in detail in the literature. Background data on toxicological endpoints (ophthalmology, clinical pathology, ECG, organ weight, histopathology and reproduction parameters) have been well-established allowing studies to be interpreted. In the context of this conference, histopathology and toxicopathology data of spontaneous or drug-induced origin are available in the scientific literature. Now there is good supply of high-quality minipigs of known disease status. There are advantages over the traditional non-rodent species in relation to the ethical difficulties of use of animals in biomedical research. Consequently, there are scientific, economic and sociological reasons that make minipigs good toxicological and pharmacological models. The principal disadvantage is that toxicity testing in minipigs may require more test compound than the traditional species.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16725317     DOI: 10.1016/j.etp.2006.03.003

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  27 in total

1.  Successful cloning of the Yucatan minipig using commercial/occidental breeds as oocyte donors and embryo recipients.

Authors:  Jose L Estrada; Bruce Collins; Abby York; Steve Bischoff; Jeff Sommer; Shengdar Tsai; Robert M Petters; Jorge A Piedrahita
Journal:  Cloning Stem Cells       Date:  2008-06

2.  Vascular access port implantation and serial blood sampling in a Gottingen minipig (Sus scrofa domestica) model of acute radiation injury.

Authors:  Maria Moroni; Thea V Coolbaugh; Jennifer M Mitchell; Eric Lombardini; Krinon D Moccia; Larry J Shelton; Vitaly Nagy; Mark H Whitnall
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-01       Impact factor: 1.232

3.  Determination of fatty acid and sphingoid base composition of eleven ceramide subclasses in stratum corneum by UHPLC/scheduled-MRM.

Authors:  Gilbert P Laffet; Alexandre Genette; Bastien Gamboa; Virginie Auroy; Johannes J Voegel
Journal:  Metabolomics       Date:  2018-05-09       Impact factor: 4.290

4.  Isolation and characterization of vascular endothelial cells derived from fetal tooth buds of miniature swine.

Authors:  Masanori Nasu; Taka Nakahara; Noriko Tominaga; Yuichi Tamaki; Yoshiaki Ide; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-22       Impact factor: 2.416

5.  Minipigs as an animal model for dermal vaccine delivery.

Authors:  Ivo H J Ploemen; Hoang J H B Hirschberg; Heleen Kraan; Adrian Zeltner; Sandra van Kuijk; Danielle P K Lankveld; Michael Royals; Gideon F A Kersten; Jean-Pierre Amorij
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

6.  Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model.

Authors:  David W Kang; Laurence Jadin; Tara Nekoroski; Fred H Drake; Monica L Zepeda
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

7.  Bama miniature pigs (Sus scrofa domestica) as a model for drug evaluation for humans: comparison of in vitro metabolism and in vivo pharmacokinetics of lovastatin.

Authors:  Yu Liu; Ben-Hua Zeng; Hai-Tao Shang; Yan-Yan Cen; Hong Wei
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

8.  The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics.

Authors:  F Josef van der Staay; Bruno Pouzet; Michel Mahieu; Rebecca E Nordquist; Teun Schuurman
Journal:  Psychopharmacology (Berl)       Date:  2009-07-23       Impact factor: 4.530

9.  Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.

Authors:  Wyatt J Roth; Candice B Kissinger; Robyn R McCain; Bruce R Cooper; Jeremy N Marchant-Forde; Rachel C Vreeman; Sophia Hannou; Gregory T Knipp
Journal:  AAPS J       Date:  2013-04-18       Impact factor: 4.009

10.  The Göttingen minipig for assessment of retinoid efficacy in the skin: comparison of results from topically treated animals with results from organ-cultured skin.

Authors:  Michael K Dame; Tejaswi Paruchuri; Marissa DaSilva; Narasimharao Bhagavathula; William Ridder; James Varani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-18       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.